![Sheraz Mian Sheraz Mian](https://staticx.zacks.com/images/mugshots/sheraz_mian/sheraz_mian-4.png)
Top Research Reports for JNJ, AT&T & Lockheed Martin
![](https://staticx.zacks.com/images/zt/ztNow_icon2.png)
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Friday June 30 2017
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), AT&T (T), and Lockheed Martin (LMT).These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Johnson & Johnson shares have gained +9.3% over the last year, widely outperforming the large-cap pharma space (up +1.6%). Driving this outperformance is JNJ's diversified business model, deep product pipeline, and financial strength. The potential Actelion buyout, though expensive, is also expected to bolster the company's long-term growth. However, in 2017, growth in J&J’s Pharma segment is expected to suffer as key growth drivers have slowed down due to competition. Estimates have remained mostly stable lately ahead of the Q2 results which come out on July 18th. J&J has a positive record of earnings surprises in the recent quarters. In the updated research report issued today, the Zacks analyst discusses the pros & cons of investing JNJ shares at present.
(You can read the full research report on Johnson & Johnson here >>>).
Operators in the U.S. wireless industry have bee suffering lately and AT&T is no different, even though it has done a tad bit better. The stock is down - 11.5% in the year-to-date period vs. -11.9% drop for the Zacks U.S. Wireless industry and -16.8% drop for Verizon (VZ). The saturated wireless market, losses in access lines, operating expenses, regulatory norms and union issues are acting as major headwinds. The company is actively engaged in upgrading its wireless business even as it fends off competitive challenges from other operators in its core business. On the diversification front, AT&T's Time Warner deal has gained the European Union’s approval but awaits U.S. Justice Department’s nod. The company's attractive dividend, currently yielding 5.1% appears safe, but these are nevertheless uncertain times in the wireless industry.
(You can read the full research report on AT&T here >>>).
Lockheed Martin shares have gained +11.6% over the past year, underperforming the aerospace/defense sector, which has gained +24.4% over the same period. However, being the largest defense contractor in the world, Lockheed Martin continues to be a strong cash generator, which, in turn, helps it to take important cash deployment decisions. The Zacks analyst likes the company’s solid presence in both domestic and international markets. Further, increased budget for the Department of Defense is expected to boost defense giants like Lockheed Martin. (You can read the full research report on Lockheed Martin here >>>).
Other noteworthy reports we are featuring today include Newell Brands (NWL), eBay (EBAY) and SunTrust Banks (STI).
Zacks' 2017 IPO Watch List
Before looking into the stocks mentioned above, you may want to get a head start on potential tech IPOs that are popping up on Zacks' radar. Imagine being in the first wave of investors to jump on a company with almost unlimited growth potential? This Special Report gives you the current scoop on 5 that may go public at any time.
One has driven from 0 to a $68 billion valuation in 8 years. Four others are a little less obvious but already show jaw-dropping growth. Download this IPO Watch List today for free >>
Sheraz Mian
Director of Research
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>
Get the latest research report on LMT - FREE
Get the latest research report on T - FREE
Get the latest research report on JNJ - FREE
Get the latest research report on NWL - FREE